Nasir Sulemanjee

Hemocompatibility Outcomes With Pharmacological Therapy Following LVAD Implantation

Jason Neil Katz, Jean M. Connors, Francis D. Pagani, Ulrich P. Jorde et autres

BACKGROUND: The ARIES-HM3 (Antiplatelet Removal and Hemocompatibility Events With the HeartMate 3 Pump) trial demonstrated safety and decreased bleeding in eliminating aspirin from the antithrombotic regimen of patients implanted with a HM3 left ventricular assist device (LVAD). Whether pharmacologic therapies impact hemocompatibility-related …

us, cz (code pays fourni par la source)

Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection Fraction

Daniel Jabr, Rachel A. Pedersen, Amogha Dahal, Manuel Paredes-Flores et autres

us (code pays fourni par la source)

Over 1,000 Heart Transplants Using Donation After Circulator Death (DCD) Donors: Real-World Experience with the Organ Care System (OCS) Heart

Y. Shudo, David A. D’Alessandro, A. Anyanwu, P. Patel et autres

Purpose: DCD donation has significantly expanded the donor pool resulting in an increased number of heart transplants (HT) in the US. This study examines the outcomes of HT from donation after circulatory death (DCD) using the OCS Heart and benchmarking it to …

us (code pays fourni par la source)

Heart Transplantation from Donation After Circulatory Death Donors: Comparison of the OCS Heart and Non-OCS Methods

D. D'Alessandro, Jacob Niall Schroder, Yasuhiro Shudo, Pujan H. Patel et autres

Purpose: Donation after circulatory death (DCD) donation has significantly expanded the donor pool resulting in increased number of heart transplants (HT). We examine the outcomes of HT from DCD direct procurement using OCS Heart (DCD-OCS) compared to DCD without OCS use (DCD …

us (code pays fourni par la source)

Organ Care System Heart Perfusion (OHP) Registry Annual Report 2024 - Donation After Brain Death (DBD) Donors

Mohamad Nur Fadjri Kai, M. Villavicencio, Lucian Lozonschi, Suguru Ohira et autres

us (code pays fourni par la source)

Organ Care System Heart Perfusion (OHP) Registry Annual Report 2024 - Donation After Circulatory Death (DCD) Donors

Anelechi Anyanwu, D. D'Alessandro, P. Patel, Y. Shudo et autres

us (code pays fourni par la source)

Comparison of Central vs Peripheral Veno-Arterial Extracorporeal Membrane Configurations in Patients Listed for Orthotopic Heart Transplantation

N. Cyrille-Superville, Sanjeev Gulati, W. Brian Saunders, Rachel A. Pedersen et autres

us (code pays fourni par la source)

PROGNOSTIC IMPLICATIONS OF CARDIOMEMS MONITORING IN CONGESTIVE HEART FAILURE PATIENTS BASED ON BASELINE HEMODYNAMIC PROFILES

Daniel Jabr, Manasi Sejpal, MANUEL PAREDES FLORES, Sunil Pauwaa et autres

us (code pays fourni par la source)

Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry

Josef Stehlik, MARYJANE A. FARR, Mandeep R. Mehra, Jacob Niall Schroder et autres

BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes in hearts recovered from extended-criteria donors after brain death (DBD) and donors after circulatory death (DCD). …

us (code pays fourni par la source)

Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease

Finn Gustafsson, Nir Y. Uriel, Ivan Netuka, Jason N. Katz et autres

Importance: The Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure (ARIES-HM3) study demonstrated that aspirin may be safely eliminated from the antithrombotic regimen after HeartMate 3 (HM3 [Abbott Cardiovascular]) left ventricular assist device (LVAD) implantation. This …

dk, us, cz, at, kz, ca, it, au (code pays fourni par la source)

Adverse outcomes in nontrial like patients on commercial HeartMate 3 LVAD support

Laura A. Coyle, Colleen T. Gallagher, Nicole Graney, Lisa Kukla et autres

Patient selection for real-world use of HeartMate 3 left ventricular assist device (HM3 LVAD) differs from that of clinical trials. We assessed adverse-event rates between “non-trial like” (NTL) and “trial like” (TL) patients who underwent commercial HM3 implantation. We conducted a multicenter, …

us (code pays fourni par la source)

Survival Into the Seventh Decade of Life Following Mustard Repair

Matthew Peters, Steven C. Port, Heather R. Sanders, Nasir Sulemanjee et autres

Atrial switch procedures (Senning and Mustard) for transposition of the great arteries have largely been abandoned for arterial switch procedures. The number of surviving patients who have undergone atrial switch procedures is declining. We present a case of the oldest known survivor …

us (code pays fourni par la source)